Abstract
Chimeric antigen receptor (CAR)-T cells have revolutionized the treatment of multiple types of hematological malignancies, but have shown limited efficacy in patients with glioblastoma (GBM) or other solid tumors. This...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have